Kenny Walter

Using the 4 JAMA benchmarks, investigators do not find any online articles that are entirely accurate and accountable.

Steroids are often prescribed for diabetic macular edema following ineffectiveness of laser photocoagulation and anti-VEGF.

A large proportion of nAMD patients treated with anti-VEGF therapies continue to have active disease and fluid.

In data presented virtually during the ASRS 2020 meeting, investigators find X-82 is non inferior in visual acuity outcomes.

The approval are based on a pair of recent phase 3 trials showing the safety and efficacy of budesonide/glycopyrrolate/formoterol fumarate.

More than 40% of critically ill patients died within 90 days regardless of timing of renal-replacement therapy.

Patients in the DBT group were less likely to drop out early and had higher rates of symptomatic remission than a comparison CPT treatment group.

The Patient Controller will join a growing list of Abbott digital care products aimed at streamlining the therapeutic experience.

Canagliflozin is a known treatment for kidney disease, as well as heart failure in patients with type 2 diabetes and diabetic nephropathy.

The ongoing COVID-19 pandemic has forced several ophthalmologists to cancel appointments with patients who might be at a risk of developing sight-threatening illnesses.

The approval represents the second approved treatment of the conditions associated with narcolepsy patients at least 7 years old.

The association of DAA treatment with mortality did not differ by sex in the cirrhosis group.

Symptom provocation did not meaningfully alter the diagnostic sensitivity and specificity that is relative to more easily obtained pretests symptom ratings.

Both telemedicine and face-to-face therapy resulted in improved daytime function.

The risk of reoffended is lower in males with 5 or more clinical contacts.

Cataracts and diabetic retinopathy are the 2 leading causes of acquired blindness worldwide.

New scoring model is based on an eight-point threshold to accurately predict patients at a low risk of adverse outcomes.

The number needed to treat to prevent at least 1 additional hospitalization was 7 individuals treated with aripiprazole once monthly compared with clinician’s choice.

There is a higher chronic kidney disease prevalence for individuals with lower educational levels.

A two-week period of downward COVID-19 cases is needed before reigniting elective procedures.

The 8-7 decision allows Mallinckrodt to move forward with a Sept. 12 PDUFA date for the investigational agent.

Patients in the multidisciplinary-care group were more likely to experience a 50% or higher reduction in all Gastrointestinal Symptom Severity Index symptom clusters than the patients who were in the standard-care group.

Chronic kidney disease and kidney failure represent the most common comorbidities for patients hospitalized with COVID-19 infections.

The estimated two-year four-variable kidney failure risk equation for individual risk using predicted ACR from PCR had discrimination similar to that of using observed ACR.

The investigators found the treatment’s value-based price was approximately $140/dose ,while the current price is $240/dose.

Intraclass correlation coefficients for short-term variability among the 7 periods during the day ranged from 0.52 in the morning period to 0.66 in the early period and long-term ICCs ranged from 0.29 at night to 0.51 during the late period.

Four out of 18 patients in antipsychotic monotherapy, 5 out of 16 individuals receiving psychological intervention, and 5 out of 17 receiving combined therapy achieved a good clinical response at 6 months.

Patients with bipolar depression have struggled during the COVID-19 pandemic.

Unlike other antidepressants, SEP-4199 looks at reducing some side effects common when treating bipolar depression.

In a sample of patients treated with laparoscopic ileocecal resection, 42% (n = 29) of patients did not require additional Crohn’s disease-related medication, while 48% (n = 14) were given prophylactic immunomodulator therapy.